Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

This bill directs the federal Department of Health and Human Services, through the National Institutes of Health, to expand research on Premenstrual Dysphoric Disorder (PMDD), support clinical trials for treatments, and collect and publish data on how common it is, its economic and workforce effects, and barriers to care. It requires a public awareness campaign about PMDD symptoms and treatment and the creation of continuing education materials to help health care providers diagnose and treat PMDD. It creates grants for medical, nursing, and pharmacy schools, hospitals, and residency programs to train health professionals on PMDD care. The Secretary must report to Congress on progress within 2 years, and the bill authorizes such sums as necessary for these activities over several fiscal years.

Full text and official record on Congress.gov

Sponsors

• Yassamin Ansari Democrat sponsor
• 29 cosponsors